Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01673438
Brief Title: Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors

First Submitted : August 21, 2012
First Submitted that Met QC Criteria : August 27, 2012
First Posted : August 28, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : April 18, 2014
Last Update Posted : April 21, 2014 (Estimate)